Send Inquiry

Request To Call Back

HEPCVIR SOFOSBUVIR TABLETS

Get a Price/Quote

HEPCVIR SOFOSBUVIR TABLETS Specification

Indication
Hepatitis C Virus (HCV) infection

CAS No
1190307-88-0

Appearance
Film-coated tablet

Assay
NLT 98%

Grade
Pharmaceutical Grade

Expiration Date
36 months from manufacturing date

Medicine Type
Allopathic

Molecular Formula
C22H29FN3O9P

Dosage
400 mg

Usage
For the treatment of chronic hepatitis C infection

Storage
Store below 30C, keep in original container

Pacakaging (Quantity Per Box)
28 Tablets

Salt Composition
Sofosbuvir

Dosage Form
Oral tablet

Origin of Medicine
India

Prescription Required
Yes

Marketed By
Cipla Ltd.

Route of Administration
Oral

Tablet Shape
Capsule-shaped

Inactive Ingredients
Microcrystalline cellulose, mannitol, croscarmellose sodium, and others

Country of Export
India

Box Dimensions
14.5 cm x 7 cm x 4 cm

Storage Condition
Protect from moisture and sunlight

Therapeutic Class
Antiviral

Colour
Yellow

HEPCVIR SOFOSBUVIR TABLETS Trade Information

Packaging Details
PACK OF 28 TABLETS

Main Domestic Market
All India

About HEPCVIR SOFOSBUVIR TABLETS

Hepcvir 400 Mg - Sofosbuvir

Hepcvir - Sofosbuvir

Specifications :-

Brand Name : Hepcvir
Generic Name : Sofosbuvir
Strength : 400mg
Packing : Pack of 28 tablets
Type : Tablets
Uses : Hepatitis Treatment Drugs
Manufactured By : Cipla

Note :-Hepcvir Is A Prescription Drug And Should Be Used Under Proper Medical Guidance And Advice. Do Not Share The Medicine With Others, Since They May Be Suffering From A Problem That Is Not Effectively Treated By This Drug.............

Advanced Antiviral Therapy for Hepatitis C

HEPCVIR Sofosbuvir Tablets offer effective treatment for chronic hepatitis C infection, leveraging the trusted expertise of Cipla Ltd. The medicine is formulated for optimal absorption with inactive ingredients such as microcrystalline cellulose and croscarmellose sodium, supporting the action of Sofosbuvir. Its precise pharmaceutical grade ensures consistent quality and efficacy in clinical management of HCV.

Safe Storage and Handling Guidelines

To maintain potency, HEPCVIR Tablets should be stored below 30C in the original container, away from moisture and sunlight. Each box measures 14.5 cm x 7 cm x 4 cm, facilitating secure storage. Proper handling and adherence to storage instructions are vital for preserving the medicines therapeutic benefits throughout its 36-month shelf life.

FAQs of HEPCVIR SOFOSBUVIR TABLETS:

Q: How should HEPCVIR Sofosbuvir Tablets be administered?

A: HEPCVIR Sofosbuvir Tablets are taken orally, as prescribed by your healthcare professional. Always swallow the medicine whole and follow your doctors instructions regarding dosage and schedule.

Q: What is the primary use of HEPCVIR Sofosbuvir Tablets?

A: The tablets are intended specifically for the treatment of chronic hepatitis C virus (HCV) infection, aiding in the reduction of viral load and improving liver health.

Q: When should I begin and stop using HEPCVIR Sofosbuvir Tablets?

A: Start using HEPCVIR only after receiving a prescription and guidance from your healthcare provider. The duration of treatment depends on your specific medical condition and your doctors recommendations.

Q: Where should I keep my HEPCVIR Tablets to maintain their effectiveness?

A: Store the tablets below 30C in their original container. Keep them protected from moisture and sunlight, following the manufacturers instructions to ensure maximum efficacy.

Q: What is the process for obtaining HEPCVIR Sofosbuvir Tablets?

A: HEPCVIR requires a valid prescription and can be obtained through authorized pharmacies, distributors, or suppliers. It is exported and distributed internationally, with Cipla Ltd. responsible for manufacturing.

Q: What are the benefits of HEPCVIR Sofosbuvir Tablets in treating hepatitis C?

A: HEPCVIR offers reliable antiviral action to combat HCV infection, helping decrease viral presence in the body, reduce liver inflammation, and increase the chances of recovery with appropriate medical supervision.

Q: Do HEPCVIR Tablets contain any inactive ingredients, and are they safe?

A: Yes, the tablets contain inactive ingredients such as microcrystalline cellulose, mannitol, and croscarmellose sodium, which support tablet stability and absorption. These are generally recognized as safe in pharmaceutical formulations.

Tell us about your requirement